PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score.

İbrahim Vedat BayoğluJavid HüseynovAlper TopalNadiye SeverNargiz MajidovaAbdussamet ÇelebiAlper YaşarRukiye ArıkanSelver IşıkMuhammed Bekir HacıoğluÖzlem ErcelepMurat SarıBülent Erdoğanİlhan HacıbekiroğluSernaz TopaloğluOsman KöstekIrfan Cicin

Published in: Journal of clinical medicine (2023)

Pre-treatment PNI, as a valuable and potential add-on biomarker to the adjusted PNI-IMDC classification model, can be helpful for establishing an improved prognostic model for intermediate group mRCC patients treated with first-line TKISs. Further validation studies are needed to clarify these findings.

Keyphrases

machine learning
deep learning
human health
combination therapy
smoking cessation